Pathway Commons

Search and visualize public biological pathway information. Single point of access.

[Pathway Commons @PathwayCommons]

Version 14 of Pathway Commons is online! Over 6 600 pathways, 3.5 million interactions from 23 sources including author-curated data from @biofactoid. Visit https://t.co/PdmibqaL2S to add your published research findings to Pathway Commons! #pathways https://t.co/GGtXn4wBcw

[Pathway Commons @PathwayCommons]

Version 12 of Pathway Commons is online! Over 5 700 pathways, 2.4 million interactions from 22 sources. #pathways https://t.co/GGtXn4wBcw

[reactome @reactome]

Just out - V68 data. New pathways & reactions supported by gene, protein, small mol & drug annotations & literature citations. Fully integrated with our #PathwayBrowser, #webservices & #graphdatabase. #genomics #biology #opendata #dataviz #dataanalyisis https://t.co/79jhrPugXb

[Pathway Commons @PathwayCommons]

Version 11 of Pathway Commons is online! Over 4 700 pathways, 2.3 million interactions from 22 sources. #pathways https://t.co/GGtXn4wBcw

[Pathway Commons @PathwayCommons]

Version 10 of Pathway Commons is online! Over 53 000 pathways, 3 million interactions from 23 sources. #pathways https://t.co/GGtXn4Oc44

[Pathway Commons @PathwayCommons]

Happy Tuesday from @PathwayCommons at #AACR18! Busy time at the poster session yesterday so ICYMI:

[Pathway Commons @PathwayCommons]

Panoramic display for #AACR18 Landmarks in Cancer Research.

[Pathway Commons @PathwayCommons]

Good morning Chicago! @PathwayCommons will be up to chat at our poster this am at #AACR2018 #AACR18! Section 12, Board: 7, Abstract: 1284

[Pathway Commons @PathwayCommons]

Lucid talk by William Hahn about complementary genomic and functional approaches; Using CRISPR and RNAi to develop their cancer dependency maps. #AACR18

[Pathway Commons @PathwayCommons]

Solved! #AACR18!

[Pathway Commons @PathwayCommons]

Just a few posters to get to at #AACR2018 #AACR18! Come chat with us Monday Apr 16, 2018 8:00 AM - 12 ,Poster Section 12, Board: 7,
Abstract: 1284

[Pathway Commons @PathwayCommons]

@AACR is it #AACR2018 or #AACR18? Fifty fifty right now.

[Pathway Commons @PathwayCommons]

#AACR18 Want to know how to summarize your blood biopsy omics data in terms of pathways? @PathwayCommons Guide gives you a step-by-step workflows: https://t.co/eduFxWKRDl… via @pathwaycommons https://t.co/bXckbael7b

[Janet Freeman-Daily @JFreemanDaily]

Opening #AACR18 plenary scientific session: Dr Klaus Panel gives overview of liquid biopsies (THE hot topic of this year’s conference) #AACR2018

[Sam Blackman @drsam]

We need to come up with a name for the phenomenon of dozens or hundreds of iPhone/iPad/camera holding hands coming up simultaneously every time a new slide is put up by a speaker.

It's a science version of #TheWave. But needs a better name.

#AACR18

[Matthew Maryniak @drug_czar]

Ira Mellman from @genentech gives one of my favorite slides, showing all of the different IO combinations in different phases of clinical trials for different cancer types. I would hate to be responsible for keeping this slide updated! #AACR18

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

Great to see former colleague George Coukos now in Lausanne speaking about harnessing immune infiltration to attack ovarian cancer. #AACR18

[Andy Biotech @AndyBiotech]

Very cool figure of 87 new and emerging molecular targets at #AACR18

https://t.co/DEbybbT8Jw via @BioCentury

[Annie Ellis @Stigetta]

Klaus Pontel re liquid biopsy: CTCs, ctDNA, ctmiRNA, platelets & exomes can provide complementary info. Validation can be achieved thru international consortia like European IMI Cancer-ID network https://t.co/P109ldE5fx #AACR2018 #AACRSSP18

[Pathway Commons @PathwayCommons]

Good morning Chicago! Neither sleet nor snow could stop @PathwayCommons from day 1 of #Aacr2018.

[Pathway Commons @PathwayCommons]

We're gearing up for #AACR2018 in Chicago! Interested in learning how to interpret your -omics data? Stop by the @pathwaycommons poster for workflows and resources (Monday 8-12, Section 12, Board 7, Abstract 1284).